To evaluate and summarize the best evidence on self-management in adult patients with systemic lupus erythematosus (SLE) and provide evidence-based recommendations in clinical settings.
Methods
Literatures related to self-management of SLE patients were searched in the guideline websites, professional association websites and relevant databases, including clinical decisions, guidelines, expert consensus, best practice recommendations, evidence summaries, meta-analyses, systematic reviews and randomized controlled trials, etc. The search time was from January 2018 to September 2023.
Results
A total of 19 literatures were included, consisting of 9 guidelines, 4 expert consensus, 4 clinical decisions, and 2 systematic reviews, and 49 pieces of evidence were extracted. After sorting and discussing, the evidence were integrated into six aspects: skin management, diet management, exercise management, vaccination management, complication management, as well as follow-up and lifestyle management.
Conclusion
The best evidence of self-management in SLE patients summarized in this study is of high quality, which can provide evidence-based recommendations for clinical medical staff and patients, so as to help self-management of SLE patients in a more scientific and effective way.
MorganCBlandARMakerC, et al.Individuals living with lupus: findings from the LUPUS UK Members Survey 2014. Lupus2018; 27: 681–687.
2.
FanouriakisATziolosNBertsiasG, et al.Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis2021; 80: 14–25.
3.
McElhoneKAbbottJGrayJ, et al.Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus2010; 19: 1640–1647.
4.
GuCZhaoRZhangX, et al.A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors. Arch Osteoporos2019; 15: 1.
5.
DörnerTFurieR. Novel paradigms in systemic lupus erythematosus. Lancet2019; 393: 2344–2358.
6.
BernatskySBoivinJ-FJosephL, et al.Mortality in systemic lupus erythematosus. Arthritis Rheum2006; 54: 2550–2557.
7.
RyanPSawinKJ. The Individual and Family Self-Management Theory: background and perspectives on context, process, and outcomes. Nurs Outlook2009; 57: 217–225.
8.
ChangAWinquistNWWescottAB, et al.Systematic review of digital and non-digital non-pharmacological interventions that target quality of life and psychological outcomes in adults with systemic lupus erythematosus. Lupus2021; 30: 1058–1077.
9.
MunnZLockwoodCMoolaS. The development and use of evidence summaries for point of care information systems: a streamlined rapid review approach. Worldviews Evid Based Nurs2015; 12: 131–138.
10.
AlperBSHaynesRB. EBHC pyramid 5.0 for accessing preappraised evidence and guidance. Evid Based Med2016; 21: 123–125.
11.
FosterMJShurtzS. Making the Critical Appraisal for Summaries of Evidence (CASE) for evidence-based medicine (EBM): critical appraisal of summaries of evidence. J Med Libr Assoc2013; 101: 192–198.
12.
BrouwersMCKhoMEBrowmanGP, et al.Agree II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol2010; 63: 1308–1311.
13.
McArthurAKlugárováJYanH, et al.Innovations in the systematic review of text and opinion. Int J Evid Based Healthc2015; 13: 188–195.
14.
AromatarisEFernandezRGodfreyCM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015; 13: 132–140.
15.
JordanZLockwoodCMunnZ, et al.Redeveloping the JBI model of evidence based healthcare. Int J Evid Based Healthc2018; 16: 227–241.
ParodisIGirard-Guyonvarc’hCArnaudL, et al.EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis2024; 83: 720–729.
21.
DrososGCVedderDHoubenE, et al.EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis2022; 81: 768–779.
22.
GwinnuttJMWieczorekMBalanescuA, et al.2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis2023; 82: 48–56.
23.
Chinese Rheumatology Association, National Clinical Research Center for Dermatologic and Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment and Research Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi. 2020; 59: 172–185.
24.
Centre for Lupus Erythematosus Research. Chinese Society of Dermatology. Guideline for diagnosis and treatment of cutaneous lupus erythematosus (2019). Chin J Dermatol2019; 52: 149–155.
25.
FurerVRondaanCHeijstekMW, et al.2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis2020; 79: 39–52.
26.
Xibillé-FriedmannDPérez-RodríguezMCarrillo-VázquezS, et al.Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology. Reumatol Clin (Engl Ed)2019; 15: 3–20.
27.
KeelingSOAlabdurubalnabiZAvina-ZubietaA, et al.Canadian Rheumatology association recommendations for the assessment and monitoring of systemic lupus erythematosus. J Rheumatol2018; 45: 1426–1439.
28.
GordonCAmissah-ArthurM-BGayedM, et al.The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology2018; 57: e1–e45.
29.
BlaessJGenetonSGoepfertT, et al.Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force. RMD Open2024; 10: e004171.
30.
ShenNZhaoYDuanL, et al.Recommendations for diagnosis and treatment of systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi2023; 62: 775–784.
31.
Expert group on low-dose interleukin-2 therapy for systemic lupus erythematosus. The recommendations for low-dose interleukin-2 therapy in systemic lupus erythematosus. Chin J Rheumatol. 2019; 23: 5–9.
32.
Chinese Rheumatism Data Center, Chinese Systemic Lupus Erythematosus Treatment and Research Group. The consensus on the diagnosis and treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus in Chinese adults. Chin J Intern Med. 2015; 54: 81–86.
33.
OkuKHamijoyoLKasitanonN, et al.Prevention of infective complications in systemic lupus erythematosus: a systematic literature review for the APLAR consensus statements. Int J Rheum Dis2021; 24: 880–895.
34.
AlexandersonHBoströmC. Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - a systematic literature review. Best Pract Res Clin Rheumatol2020; 34: 101547.
35.
EstadtSNMazMPMusaiJ, et al.Mechanisms of photosensitivity in autoimmunity. J Invest Dermatol2022; 142: 849–856.
36.
BarbhaiyaMHartJEMalspeisS, et al.Association of ultraviolet B radiation and risk of systemic lupus erythematosus among women in the Nurses’ health studies. Arthritis Care Res2023; 75: 1409–1415.
37.
SabioJMBetolazaSDVargas-HitosJA. Characteristics and safety of tattoos in patients with systemic lupus erythematosus. Lupus2019; 28: 1250–1254.
38.
KuckuckSvan der ValkESScheurinkAJW, et al.Glucocorticoids, stress and eating: the mediating role of appetite-regulating hormones. Obes Rev2023; 24: e13539.
39.
CornetAAndersenJMyllysK, et al.Living with systemic lupus erythematosus in 2020: a European patient survey. Lupus Sci Med2021; 8: e000469.
40.
KiftRCWebbAR. Globally estimated UVB exposure times required to maintain sufficiency in vitamin D levels. Nutrients2024; 16: 1489.
41.
O’DwyerTDurcanLWilsonF. Exercise and physical activity in systemic lupus erythematosus: a systematic review with meta-analyses. Semin Arthritis Rheum2017; 47: 204–215.
42.
BarberMRWDrenkardCFalasinnuT, et al.Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol2021; 17: 515–532.
43.
RondaanCFurerVHeijstekMW, et al.Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations. RMD Open2019; 5: e001035.
44.
GergianakiIGarantziotisPAdamichouC, et al.High comorbidity burden in patients with SLE: data from the community-based lupus registry of crete. J Clin Med2021; 10: 998.
45.
AndradeSOJulioPRNunes de Paula FerreiraD, et al.Predicting lupus flares: epidemiological and disease related risk factors. Expert Rev Clin Immunol2021; 17: 143–153.
46.
GergianakiIBortoluzziABertsiasG. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol2018; 32: 188–205.
